Faron, etusivu

releases and publications

Holding(s) in the Company

Shareholder announcement Regulatory

Registration of Placing Shares

Regulatory

Results of Placing and Issue Price

Regulatory

Proposed Issue and Placing of Shares

Regulatory

Update on TRAUMAKINE development

Regulatory

Bexmarilimab (Clevegen) development update

Regulatory

US Department of Defense (DoD) to support TRAUMAKINE development

Regulatory

Faron to Present at H.C. Wainwright BioConnect

Faron’s financial calendar for 2021

Regulatory

Presentations at ESMO Immuno-Oncology Virtual Congress build case for CLEVER-1 as a new immune checkpoint target

Regulatory
PreviousNext
Back to top